GH1 and cardiac hypertrophy: However, a potential complicating factor of growth hormone treatment for COVID-19 is that acromegaly, a state of endogenous GH excess, results in myocardial hypertrophy and decreased cardiac performance with increased cardiovascular mortality [153].